Literature DB >> 28869167

Determinants associated with the correction of glomerular hyper-filtration one year after bariatric surgery.

Guillaume Favre1, Rodolphe Anty2, Clémence Canivet2, Gabrielle Clément3, Imed Ben-Amor4, Albert Tran2, Jean Gugenheim2, Philippe Gual5, Vincent L M Esnault6, Antonio Iannelli2.   

Abstract

BACKGROUND: Increased adipokine production and hyperfiltration may explain the links between obesity and chronic kidney disease. Indeed, hyperfiltration may precede a subsequent accelerated decline of kidney function in these patients. Glomerular filtration rate decreases after bariatric surgery in young obese patients with hyperfiltration.
OBJECTIVE: Our aim was to identify the factors associated with this decrease 1 year after bariatric surgery.
SETTING: We used data from a prospective cohort of severely obese patients who underwent bariatric surgery in Nice University Hospital.
METHODS: We analyzed 175 patients before and 1 year after bariatric surgery. Low-grade inflammation was evaluated by serum C-reactive protein levels. Lean body mass and fat body mass were estimated by bioelectric impedance analysis. Body surface area was assessed by the Du Bois formula. Serum creatinine levels were used to estimate glomerular filtration rate by the chronic kidney disease-epidemiology collaboration (CKD-EPI) equation. Glomerular filtration rate was de-adjusted from standard body surface area and then divided by lean body mass to calculate the decrease in hyperfiltration and to separate the patients into 2 groups: above or below the median decrease of hyperfiltration after bariatric surgery.
RESULTS: The factors associated with a large correction of hyperfiltration were baseline C-reactive protein levels (10.0 ± 5.8 mg/L versus 12.7 ± 7.4 mg/L, P = .01) and brachial circumference (41 ± 4 cm versus 44 ± 5 cm, P = .006). A high fat mass reduction rate was significantly associated with a substantial hyperfiltration reduction after bariatric surgery (P<.001) independently of sex and surgical procedure.
CONCLUSIONS: The correction of hyperfiltration is associated with a high reduction rate of fat mass after bariatric surgery but may be limited by low-grade inflammation.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Bariatric surgery; Glomerular hyper-filtration; Obesity

Mesh:

Substances:

Year:  2017        PMID: 28869167     DOI: 10.1016/j.soard.2017.07.018

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  5 in total

1.  Renal Function 1 Year After Bariatric Surgery: Influence of Roux-en-Y Gastric Bypass and Identification of Pre-Operative Predictors of Improvement.

Authors:  Milena Silva Garcia; Davi Reis Calderoni; Laísa Simakawa Jimenez; José Carlos Pareja; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

Review 2.  Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Moein Askarpour; Dana Khani; Ali Sheikhi; Ehsan Ghaedi; Shahab Alizadeh
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 3.  Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.

Authors:  Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2020-06-26       Impact factor: 15.534

4.  Extracellular fluid volume: A suitable indexation variable to assess impact of bariatric surgery on glomerular filtration rate in patients with chronic kidney disease.

Authors:  Caroline Grangeon-Chapon; Audrey Laurain; Vincent L M Esnault; Coralie Cruzel; Antonio Iannelli; Guillaume A Favre
Journal:  PLoS One       Date:  2021-08-16       Impact factor: 3.240

5.  Exploring Renal Changes after Bariatric Surgery in Patients with Severe Obesity.

Authors:  Anna Oliveras; Susana Vázquez; María José Soler; Isabel Galceran; Xavier Duran; Albert Goday; David Benaiges; Marta Crespo; Julio Pascual; Marta Riera
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.